Srougi M - Search Results

1

Prognostic value of TERF1 expression in prostate cancer.

Dos Santos GA, Viana NI, Pimenta R, Guimarães VR, de Camargo JA, Romão P, Reis ST, Leite KRM, Srougi M. Dos Santos GA, et al. Among authors: srougi m. J Egypt Natl Canc Inst. 2021 Sep 6;33(1):24. doi: 10.1186/s43046-021-00082-4. J Egypt Natl Canc Inst. 2021. PMID: 34486082

2

Analysis of p53 expression and proliferative assessment using PCNA in localized prostate carcinoma.

Leite KR, Srougi M, Nesralhah LJ, Camara-Lopes LH. Leite KR, et al. Among authors: srougi m. Braz J Med Biol Res. 1999 Mar;32(3):283-8. doi: 10.1590/s0100-879x1999000300006. Braz J Med Biol Res. 1999. PMID: 10347785 Free article.

3

Urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy: a randomized prospective trial.

Srougi M, Nesrallah LJ, Kauffmann JR, Nesrallah A, Leite KR. Srougi M, et al. J Urol. 2001 Mar;165(3):815-8. J Urol. 2001. PMID: 11176476 Clinical Trial.

4

Abnormal expression of MDM2 in prostate carcinoma.

Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carvalho CM, Meirelles MI, Santana I, Camara-Lopes LH. Leite KR, et al. Among authors: srougi m. Mod Pathol. 2001 May;14(5):428-36. doi: 10.1038/modpathol.3880330. Mod Pathol. 2001. PMID: 11353053 Free article.

5

Incidental and symptomatic renal tumors: impact on patient survival.

Dall'Oglio MF, Srougi M, Gonçalves PD, Leite K, Nesrallah L, Hering F. Dall'Oglio MF, et al. Among authors: srougi m. Sao Paulo Med J. 2002 Nov 1;120(6):165-9. doi: 10.1590/s1516-31802002000600002. Epub 2003 Jan 22. Sao Paulo Med J. 2002. PMID: 12563422 Free article.

6

Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.

Gonçalves PD, Srougi M, Dall'lio MF, Leite KR, Ortiz V, Hering F. Gonçalves PD, et al. Among authors: srougi m. J Urol. 2004 Aug;172(2):470-4. doi: 10.1097/01.ju.0000130582.31467.30. J Urol. 2004. PMID: 15247705

7

The role of HER2/neu, BCL2, p53 genes and proliferating cell nuclear protein as molecular prognostic parameters in localized prostate carcinoma.

Fonseca GN, Srougi M, Leite KR, Nesrallah LJ, Ortiz V. Fonseca GN, et al. Among authors: srougi m. Sao Paulo Med J. 2004 May 6;122(3):124-7. doi: 10.1590/s1516-31802004000300009. Epub 2004 Sep 16. Sao Paulo Med J. 2004. PMID: 15448811 Free article.

8

Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy.

Dall'Oglio MF, Sant'Anna AC, Antunes AA, Nesrallah LJ, Leite KR, Srougi M. Dall'Oglio MF, et al. Among authors: srougi m. Int Braz J Urol. 2004 Nov-Dec;30(6):472-8. doi: 10.1590/s1677-55382004000600004. Int Braz J Urol. 2004. PMID: 15663804 Free article.

9

Assessment of stage T1 (TNM 1997) for renal cell carcinoma: is recommended the subdivision in T1a and T1b?

Dall'Oglio M, Srougi M, Mangini M, Ribeiro E, Ferraz M, Sañudo A, Leite K, Nesrallah L. Dall'Oglio M, et al. Among authors: srougi m. Int Braz J Urol. 2003 Mar-Apr;29(2):106-11; discussion 111-2. doi: 10.1590/s1677-55382003000200003. Int Braz J Urol. 2003. PMID: 15745492 Free article.

10

Sarcomatoid differentiation in renal cell carcinoma: prognostic implications.

Dall'Oglio MF, Lieberknecht M, Gouveia V, Sant'Anna AC, Leite KR, Srougi M. Dall'Oglio MF, et al. Among authors: srougi m. Int Braz J Urol. 2005 Jan-Feb;31(1):10-6. doi: 10.1590/s1677-55382005000100003. Int Braz J Urol. 2005. PMID: 15763002 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

661 results

Search Page